Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-014313
Filing Date
2017-11-17
Accepted
2017-11-17 16:32:21
Documents
1
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7107
  Complete submission text file 0001179110-17-014313.txt   8318
Mailing Address
Business Address
LYNCH DANIEL (Reporting) CIK: 0001177082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 171211405

Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations